Asia Media News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Media News.

Press releases published on October 5, 2026

Oct. 5, 2026

Phunware to Present and Host One-on-One Meetings at the LD Micro 20th Annual Main Event on Tuesday, October 20, 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

AIB Data Centers to Present and Host One-on-One Meetings at the LD Micro 20th Annual Main Event on Wednesday, October 21, 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

EM&T to Host Operational Showcase of the Largest High-Performance Rare Earth Magnet Facility in Production Outside China on December 17, 2026, Anchoring Expansion to 10,000+ Metric Tons of Annual Capacity

Indeterminate GlobeNewswire

Oct. 5, 2026

COMSTOCK RESOURCES, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS DATE AND CONFERENCE CALL INFORMATION

Indeterminate GlobeNewswire

Oct. 5, 2026

Aprea Therapeutics to Present at October Conferences

Indeterminate GlobeNewswire

Oct. 5, 2026

Autolus Therapeutics to Present Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Wood Mackenzie connects trusted energy intelligence with Microsoft Copilot

Indeterminate GlobeNewswire

Oct. 5, 2026

Music Industry Community Brings Music, Networking, and Industry Connections to Chase Bell and LIRA’s “Do Me” Live Experience

Indeterminate GlobeNewswire

Oct. 5, 2026

Noodle & Boo Introduces Drool Baby™: Finally, Comfort for the Drooliest Days

Indeterminate GlobeNewswire

Oct. 5, 2026

Medela Recognised by Australian Mums with Three MumPower Approved™ Seals

Indeterminate EIN Presswire

Oct. 5, 2026

Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101

Indeterminate GlobeNewswire

Oct. 5, 2026

ASML reports transactions under its current share buyback program

Indeterminate GlobeNewswire

Oct. 5, 2026

Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing

Indeterminate GlobeNewswire

Oct. 5, 2026

Ensimmäinen potilas on saanut hoitoa Orion Pharman Faasi 1/2 -tutkimuksessa ODM-216-molekyylillä, joka on yhtiön ensimmäinen kliiniseen kehitysvaiheeseen edennyt biologinen syöpälääkeaihio

Indeterminate GlobeNewswire

Oct. 5, 2026

BEYYON Rechargeable Hand Warmers with LED Displays: Two Market-Tested Cold-Weather Essentials, Each in a 2-Pack

Indeterminate GlobeNewswire

Oct. 5, 2026

Safety in Action® Conference Celebrates 40 Years of Advancing Workplace Safety in 2027

Indeterminate GlobeNewswire

Oct. 5, 2026

PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Airsys and Shell Showcase Spray Liquid Cooling for Data Centers at OCP Global Summit

Indeterminate GlobeNewswire

Oct. 5, 2026

4DMT to Host Investor Day on October 21, 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Aeroplan Members Can Multiply Their Impact for Children Travelling for Essential Medical Care During Points Matching Week

Indeterminate GlobeNewswire